| pubmed-article:15801997 | pubmed:abstractText | To evaluate the resource consumption and outcomes associated with first-line monotherapy for community-acquired pneumonia, focusing specifically on the use of erythromycin, azithromycin, clarithromycin, and levofloxacin. Study design: Retrospective managed care database analysis. | lld:pubmed |
